The total number of GLP-1 users is expected to increase significantly over the coming years as pharma expands production capacity, reduces prices, develops new products with fewer side effects, and offers more user-friendly dosage forms
Novo Nordisk and other manufacturers of the hugely popular weight loss drugs have been competing against compounding pharmacies, some clinics and medical spas who sell cheaper versions of the branded medications
Firstly, the way that the different drug concentration varies over time seems to play a part, for some people at least, in the short term effectiveness of it
This is one of the most psychologically challenging moments in the entire GLP-1 journey, and it is also one of the most misunderstood
PMID: 38925559
Obesity is linked to a wide range of health conditions, including heart disease, diabetes, cancer, and stroke